Add BrightSurf on Google Email

Majority of community facilities performing breast MRI exams meet ACRIN and EUSOBI technical requirements

A study by the American College of Radiology found that nearly all US community facilities performing breast MRI exams meet ACRIN and EUSOBI technical requirements. The Breast Cancer Surveillance Consortium data revealed excellent adherence to equipment recommendations, with 94% of scanners using a dedicated breast coil.

SourceAmerican College of Radiology·JournalJournal of the American College of Radiology·DateNov 1, 2010

U of M researchers identify possible key to treating, understanding post-traumatic stress disorder

Researchers at U of M Medical School and Minneapolis VA Medical Center discovered a correlation between increased circuit activity in the right side of the brain and involuntary flashbacks triggered by PTSD. The magnetic test, called Magnetoencephalography (MEG), reveals differences in brain activity among those with PTSD compared to h...

SourceUniversity of Minnesota·JournalJournal of Neural Engineering·DateOct 28, 2010

Reviving the FDA: NEJM perspective

Georgetown University School of Medicine family medicine physician Susan Okie provides an overview of changes made by the FDA under Commissioner Margaret Hamburg. The FDA has adopted a more proactive approach to its public health mission, and is working to address growing pains within the agency.

SourceGeorgetown University Medical Center·JournalNew England Journal of Medicine·DateOct 6, 2010

LA BioMed researcher to receive prestigious honor

Dr. Casaburi will receive the award on Oct. 8 at the American Association of Cardiovascular and Pulmonary Rehabilitation's annual meeting in Milwaukee, recognizing his many contributions to the field of respiratory research and pulmonary rehabilitation. He is a leading researcher at LA BioMed, directing the Rehabilitation Clinical Tria...

What is stopping timely stroke care in the UK?

A recent report from the UK Vascular Society and Royal College of Physicians reveals patients in the UK are waiting too long for vascular surgery after stroke or TIA symptoms. The main causes of delays include delayed referral, scarcity of staff or operating theatres, and patient presentation issues.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJul 29, 2010

A chemical to make brain cells grow

Researchers discovered a chemical that promotes brain cell growth, potentially leading to new treatments for Alzheimer's and neurodegenerative diseases. The substance protects newborn neurons from dying off, giving them better odds of becoming functional cells.

SourceCell Press·JournalCell·DateJul 8, 2010

A Palestinian perspective on aid

A Palestinian perspective on aid critiques the politics behind aid provided to the occupied territory, highlighting how it maintains an unacceptable situation. The authors argue that generous aid subsidizes Israel's expansion and perpetuates donor dependency, with 42% of health expenditure financed by donors.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJul 1, 2010

Selective estrogen targeting to protect the heart and blood vessels

Researchers discovered an estrogen-dendrimer conjugate that selectively targets heart-protective pathways in mice, promoting cardiovascular protection without stimulating uterine enlargement or breast cancer growth. The findings pave the way for potential therapeutic interventions targeting non-nuclear estrogen receptors.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJun 23, 2010

Little is understood about alcohol's effect on fetal development, Georgetown researchers say

Researchers at Georgetown University Medical Center found that no new medical strategies exist to prevent or treat fetal alcohol syndrome, a disorder caused by alcohol exposure during pregnancy. Despite ongoing research, sensitive diagnostic tools are lacking, and more investigation is needed into biomarkers and prevention programs.

SourceGeorgetown University Medical Center·JournalDevelopmental Neuroscience·DateJun 16, 2010

Combination therapy targets stubborn leukemia stem cells

Researchers discover a combination of drugs that effectively target stubborn leukemia stem cells, which often escape standard treatment and lead to disease relapse. The study supports clinical trials of HDACi in combination with tyrosine kinase inhibitors to eliminate leukemia stem cells in patients with CML.

SourceCell Press·JournalCancer Cell·DateMay 17, 2010

1 of LA BioMed's founders to be honored

The American College of Physicians has awarded the Ralph O. Claypoole Sr. Memorial Award to Dr. Melvin R. Kaplan, one of LA BioMed's founders and a renowned internist. Dr. Kaplan has dedicated his career to patient care for over 60 years.

Dispensing prescription drugs in 3-month supplies reduces drug costs by a third

A new study from the University of Chicago Medical Center found that purchasing prescription drugs in three-month supplies rather than one-month supplies can reduce out-of-pocket costs by an average of 29% for patients. The total savings, including third-party payers, averaged 18%, with estimated annual savings of $148.6 million.

SourceUniversity of Chicago Medical Center·JournalApplied Health Economics and Health Policy·DateNov 20, 2009